Beranda › Kanker Paru Sel Kecil › New York

Uji klinis Kanker Paru Sel Kecil di New York

31 studi untuk Kanker Paru Sel Kecil mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

Menerima pesertaFase 1/2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

MSK Commack, Commack
MSK Westchester, East White Plains
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
dan 3 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07476287

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

GSK Investigational Site, East Syracuse

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07099898

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

START New York, Lake Success

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07488676

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Memorial Sloan Kettering Cancer Center Head Neck Services, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

START New York, Lake Success

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07730021

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

Roswell Park Cancer Institute, Buffalo

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07325136

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Stony Brook Cancer Center, Stony Brook
Montefiore Medical Center, The Bronx

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07218146

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Roswell Park Cancer Institute ( Site 1107), Buffalo

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06780137

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, New York

Menerima pesertaFase 1/2

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07038343

A Study of Armored CAR T Cells in People With Cancer

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
dan 1 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07783477

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
White Plains Hospital, White Plains

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06712355

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Montefiore Medical Center- Montefiore Medical Park, The Bronx

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07057791

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Memorial Sloan Kettering, New York

Menerima pesertaFase 1/2

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06726148

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Memorial Sloan Kettering Cancer Center (MSKCC), New York
Icahn School of Medicine at Mount Sinai PRIME, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

NYU Langone Health, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07488923

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

New York University Cancer Institute, New York

Menerima pesertaFase 1

Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07531095

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT04199741

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
dan 1 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06807632

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Clinical Research Alliance, Inc, Lake Success
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
New York University Cancer Center - Laura and Isaac, New York
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06203210

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Montefiore Medical Center, The Bronx

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05882058

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Columbia University Medical Center - Herbert Irving Pavilion, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07174583

A Study of LY4175408 in Participants With Advanced Cancer

Columbia University, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT07046923

A Study of Hospital-at-Home for People Receiving Tarlatamab

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
dan 1 lainnya

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06957314

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Memorial Sloan Kettering Suffolk - Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT05419076

Lung Cancer Biomarkers and Screening

NYU Cancer Institute at New York University Medical Center, New York

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 50 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT00301119

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Roswell Park Cancer Institute, Buffalo
University of Rochester, Rochester
Wilmot Cancer Institute at Webster, Webster

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Mar 2026 · NCT06769126

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Weill Cornell Medicine, Cornell University (site 126), New York

Menerima pesertaFase 1/2

Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT03556228

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 107, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT05914116

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Icahn School of Medicine at Mount Sinai, New York

Menerima pesertaStudi observasional

Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 19 Mar 2025 · NCT06717243

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.